🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to describe the different treatment time, treatment mode an...
Status
Unknown
Location
Henan cancer hospital
Start Date
2022-05-30
Trial ID
NCT05359120
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
Pyrotinib is an oral tyrosine kinase inhibitor targeting both EGFR and HER-...
Status
Completed
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2014-08
Trial ID
NCT02361112
Treatments Being Tested
Trastuzumab resistance, which is a common therapeutic challenge in HER2 pos...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2019-06-26
Trial ID
NCT04001621
Treatments Being Tested
Given that pyrotinib has been proven to exert significant efficacy against ...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-07-06
Trial ID
NCT07600164
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of Camrelizumab ...
Status
Unknown
Location
270 Dongan Road, Fudan University Shanghai Cancer Center
Start Date
2021-12-31
Trial ID
NCT05111444
Treatments Being Tested
This study evaluates the efficacy and safety of SRT combined with pyrotinib...
Status
Unknown
Location
Jiangxi Cancer Hospital of Nanchang University
Start Date
2022-03-01
Trial ID
NCT05042791
Treatments Being Tested
Brain metastases occur in 30-50% of patients with metastatic HER2-positive ...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2020-01-02
Trial ID
NCT04582968
Treatments Being Tested
To evaluate the efficacy and safety of pyrotinib combined with capecitabine...
Status
Unknown
Location
Qingdao University Hospital
Start Date
2020-01-10
Trial ID
NCT04227041
Treatments Being Tested
To evaluate the efficacy of continuation targeted therapy compared with tra...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2021-07-02
Trial ID
NCT05292742
Treatments Being Tested